Published in Diabetologia on May 30, 2009
Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ Res (2012) 2.78
Relationship of visit-to-visit and ambulatory blood pressure variability to vascular function in African Americans. Hypertens Res (2011) 2.03
Dextran hydrogel scaffolds enhance angiogenic responses and promote complete skin regeneration during burn wound healing. Proc Natl Acad Sci U S A (2011) 1.24
Endothelial abnormalities in adolescents with type 1 diabetes: a biomarker for vascular sequelae? J Pediatr (2010) 1.18
Circulating endothelial progenitor cells and large artery structure and function in young subjects with uncomplicated type 1 diabetes. Cardiovasc Diabetol (2011) 1.13
Carotid intima-media thickness as a surrogate marker of cardiovascular disease in diabetes. Diabetes Metab Syndr Obes (2011) 1.05
Endothelial progenitor cells in cardiovascular disease and chronic inflammation: from biomarker to therapeutic agent. Biomark Med (2011) 0.92
Endothelial progenitor cells are related to glycemic control in children with type 1 diabetes over time. Diabetes Care (2013) 0.90
Circulating vascular progenitor cells in patients with type 1 diabetes and microalbuminuria. Diabetes Care (2010) 0.88
Emerging roles of hematopoietic cells in the pathobiology of diabetic complications. Trends Endocrinol Metab (2014) 0.85
Subclinical vascular endothelial dysfunctions and myocardial changes with type 1 diabetes mellitus in children and adolescents. Pediatr Cardiol (2014) 0.84
Vascular Ageing and Exercise: Focus on Cellular Reparative Processes. Oxid Med Cell Longev (2015) 0.83
Flow cytometry and laser scanning cytometry, a comparison of techniques. J Clin Monit Comput (2010) 0.83
Association of colony-forming units with coronary artery and abdominal aortic calcification. Circulation (2010) 0.83
Influence of insulin and glargine on outgrowth and number of circulating endothelial progenitor cells in type 2 diabetes patients: a partially double-blind, randomized, three-arm unicenter study. Cardiovasc Diabetol (2014) 0.83
Circulating endothelial and progenitor cells: Evidence from acute and long-term exercise effects. World J Cardiol (2012) 0.82
Assessment of endothelial dysfunction in childhood obesity and clinical use. Oxid Med Cell Longev (2013) 0.81
The relationship between early atherosclerosis and endothelial dysfunction in type 1 diabetic patients as evidenced by measurement of carotid intima-media thickness and soluble CD146 levels: a cross sectional study. Cardiovasc Diabetol (2013) 0.80
Metformin improves circulating endothelial cells and endothelial progenitor cells in type 1 diabetes: MERIT study. Cardiovasc Diabetol (2016) 0.78
Circulating angiogenic cell populations, vascular function, and arterial stiffness. Atherosclerosis (2011) 0.77
Stem cells and diabetic cardiomyopathy: from pathology to therapy. Heart Fail Rev (2016) 0.77
Effects of glucose control and variability on endothelial function and repair in adolescents with type 1 diabetes. ISRN Endocrinol (2013) 0.77
The inflammation, vascular repair and injury responses to exercise in fit males with and without Type 1 diabetes: an observational study. Cardiovasc Diabetol (2015) 0.77
Stem cell therapies in the treatment of diabetic retinopathy and keratopathy. Exp Biol Med (Maywood) (2015) 0.76
Enhanced Integrin α4β1-Mediated Adhesion Contributes to a Mobilization Defect of Endothelial Progenitor Cells in Diabetes. Diabetes (2016) 0.75
The effect of vitamin C on endothelial function of children with type 1 diabetes: an experimental study. Int J Prev Med (2014) 0.75
Endothelial Progenitor Cells as a Marker of Endothelial Dysfunction and Atherosclerosis in Ankylosing Spondylitis: A Cross-Sectional Study. Int J Angiol (2016) 0.75
Abnormal phosphorylation of Tie2/Akt/eNOS signaling pathway and decreased number or function of circulating endothelial progenitor cells in prehypertensive premenopausal women with diabetes mellitus. BMC Endocr Disord (2016) 0.75
Evaluation of Coagulation Profile in Children with Type 1 Diabetes Mellitus Using Rotational Thromboelastometry. Indian J Hematol Blood Transfus (2017) 0.75
A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes. Diabetologia (2008) 4.62
Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet (1996) 4.32
Sucrose-negative variants of Candida tropicalis. J Clin Microbiol (1977) 3.48
Response of aequorin bioluminescence to rapid changes in calcium concentration. Nature (1969) 3.10
Treatment of falciparum malaria from Vietnam with a phenanthrene methanol (WR 33063) and a quinoline methanol (WR 30090). Antimicrob Agents Chemother (1973) 2.23
Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene (2001) 2.22
CAL1, a gene required for activity of chitin synthase 3 in Saccharomyces cerevisiae. J Cell Biol (1991) 2.07
Radiation-reduction strategies in cardiac computed tomographic angiography. Clin Radiol (2010) 1.88
Physiological and DNA characterization of Candida maltosa, a hydrocarbon-utilizing yeast. Arch Microbiol (1975) 1.83
The patient-physician relationship. Teaching the human dimensions of care in clinical settings. JAMA (2001) 1.81
Mutation analysis in Canadian families with choroideremia. Ophthalmic Genet (1996) 1.69
The retrospective diagnosis of a second outbreak of equine morbillivirus infection. Aust Vet J (1996) 1.64
Severe hyponatraemia: investigation and management in a district general hospital. J Clin Pathol (2002) 1.63
Intensive attention improves glycaemic control in insulin-dependent diabetes without further advantage from home blood glucose monitoring: results of a controlled trial. Br Med J (Clin Res Ed) (1982) 1.61
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. BJU Int (2010) 1.60
A biochemically distinct form of cytochrome oxidase (COX) deficiency in the Saguenay-Lac-Saint-Jean region of Quebec. Am J Hum Genet (1993) 1.57
Harvey Cushing and the regulation of blood pressure in giraffe, rat and man: introducing 'Cushing's mechanism'. Exp Physiol (2008) 1.51
Three-dimensional reconstruction of human coronary and peripheral arteries from images recorded during two-dimensional intravascular ultrasound examination. Circulation (1991) 1.50
Effect of high dose inhaled beclomethasone dipropionate on carbohydrate and lipid metabolism in normal subjects. Thorax (1987) 1.48
New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3). Diabetes Obes Metab (2015) 1.47
Applicability of estimated glomerular filtration rate in stratifying chronic kidney disease. Scand J Clin Lab Invest (2007) 1.46
Plasmodium falciparum strains from Papua New Guinea: culture characteristics and drug sensitivity. Southeast Asian J Trop Med Public Health (1980) 1.46
Safety of continuous subcutaneous insulin infusion: metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion. Diabetologia (1982) 1.46
A comparison of duration of first prescribed insulin therapy in uncontrolled type 2 diabetes. Diabetes Res Clin Pract (2011) 1.44
Chitinase and chitin synthase 1: counterbalancing activities in cell separation of Saccharomyces cerevisiae. J Gen Microbiol (1992) 1.42
The UK Diabetes Dataset: a standard for information exchange. Diabetes Audit Working Group of the Research Unit of the Royal College of Physicians. British Diabetic Association. Diabet Med (1995) 1.42
Clinical, metabolic, and genetic aspects of cytochrome C oxidase deficiency in Saguenay-Lac-Saint-Jean. Am J Hum Genet (1993) 1.40
Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results. J Vasc Surg (1998) 1.40
Diabetes care in general practice: an approach to audit of process and outcome. Br J Gen Pract (1993) 1.40
The effect of flavin isomers and analogues upon the color of bacterial bioluminescence. J Biol Chem (1969) 1.38
A fifteen-month double-blind cross-over study of the efficacy and antigenicity of human and pork insulins. Diabet Med (1984) 1.37
Basal and 24-h C-peptide and insulin secretion rate in normal man. Diabetologia (1987) 1.36
Cardiovascular risk assessment using pulse pressure in the first national health and nutrition examination survey (NHANES I). Hypertension (2001) 1.36
Strand-separating conformational polymorphism analysis: efficacy of detection of point mutations in the human ornithine delta-aminotransferase gene. Genomics (1992) 1.35
Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart. Diabet Med (2006) 1.33
Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption. Br Med J (Clin Res Ed) (1981) 1.32
Children's weights: guess or measure by tape? Lancet (1999) 1.32
Cell-mediated immunity in experimental Nocardia asteroides infection. Infect Immun (1977) 1.29
The relationship between tourniquet pressure and underlying soft-tissue pressure in the thigh. J Bone Joint Surg Am (1982) 1.28
Association of low birth weight with beta cell function in the adult first degree relatives of non-insulin dependent diabetic subjects. BMJ (1993) 1.27
Effect of infarct artery patency on prognosis after acute myocardial infarction. The Survival and Ventricular Enlargement Investigators. Circulation (1995) 1.26
Distal splenorenal shunt vs. portal-systemic shunt: current status of a controlled trial. Hepatology (1981) 1.24
Metalloproteinases are involved in lipopolysaccharide- and tumor necrosis factor-alpha-mediated regulation of CXCR1 and CXCR2 chemokine receptor expression. Blood (1999) 1.22
Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in Type 1 and Type 2 diabetic patients. Diabet Med (2002) 1.20
Diagnostic confusion in diabetes with persistence of fetal haemoglobin. BMJ (1992) 1.20
Detection of HER2 amplification in circulating free DNA in patients with breast cancer. Br J Cancer (2011) 1.19
The plastid in Plasmodium falciparum asexual blood stages: a three-dimensional ultrastructural analysis. Protist (1999) 1.17
Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells. J Pathol (2003) 1.16
Experimental oral immunization with L-forms of Vibrio cholerae. Infect Immun (1972) 1.13
General practice research. Problems and solutions in participant recruitment and retention. Aust Fam Physician (2001) 1.13
CXCR1 and CXCR2 are rapidly down-modulated by bacterial endotoxin through a unique agonist-independent, tyrosine kinase-dependent mechanism. J Immunol (1998) 1.12
"Hypersexuality" and behavioral changes in cats caused by administration of p-chlorophenylalanine. Science (1970) 1.11
A comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: an observational database study. Int J Clin Pract (2010) 1.10
Intermediate acting insulin given at bedtime: effect on blood glucose concentrations before and after breakfast. Br Med J (Clin Res Ed) (1983) 1.09
Agglutinin and vibriocidal responses of L forms of Vibrio cholerae and El tor. Indian J Med Res (1971) 1.09
Use of gamma irradiation to eliminate DNA contamination for PCR. Nucleic Acids Res (1990) 1.09
The mind your health project: a randomized controlled trial of an innovative behavioral treatment for obesity. Obesity (Silver Spring) (2013) 1.08
A dataset to allow exchange of information for monitoring continuing diabetes care. The Diabetes Audit Working Group. Diabet Med (1993) 1.08
The N363S polymorphism of the glucocorticoid receptor: potential contribution to central obesity in men and lack of association with other risk factors for coronary heart disease and diabetes mellitus. J Clin Endocrinol Metab (2001) 1.06
Selective REM sleep deprivation and compensation phenomena in the rat. Brain Res (1967) 1.04
Comparative evaluation of enzyme-linked immunosorbent assay for the diagnosis of pulmonary echinococcosis. J Clin Microbiol (1986) 1.04
Phaeochromocytomas presenting as acute crises after beta blockade therapy. Clin Endocrinol (Oxf) (2006) 1.04
Burnout in direct care staff in intellectual disability services: a factor analytic study of the Maslach Burnout Inventory. J Intellect Disabil Res (2004) 1.04
Glomerular expression of nephrin is decreased in acquired human nephrotic syndrome. Nephrol Dial Transplant (1999) 1.03
Hepatic and muscular presentations of carnitine palmitoyl transferase deficiency: two distinct entities. Pediatr Res (1988) 1.03
Type 1 hereditary tyrosinemia. Evidence for molecular heterogeneity and identification of a causal mutation in a French Canadian patient. J Clin Invest (1992) 1.02
Octanoic acidemia and octanoylcarnitine excretion with dicarboxylic aciduria due to defective oxidation of medium-chain fatty acids. J Pediatr (1985) 1.02
The longitudinal axis of the knee and the role of the cruciate ligaments in controlling transverse rotation. J Bone Joint Surg Am (1974) 1.01
Factors influencing initial choice of insulin therapy in a large international non-interventional study of people with type 2 diabetes. Diabetes Obes Metab (2012) 1.00
Cell-mediated immunity to Nocardia asteroides induced by its ribonucleic acid protein fraction. Infect Immun (1977) 1.00
Summary of the practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry (2001) 1.00
LMTK3 is implicated in endocrine resistance via multiple signaling pathways. Oncogene (2012) 1.00
Diagnosing the undiagnosed with diabetes. BMJ (1994) 1.00
Cell-mediated immunity to Vibrio cholerae with ribonucleic acid-protein fractions of V. cholerae L-form lysates. Infect Immun (1976) 1.00
Porcine stress syndromes. Adv Food Res (1982) 1.00
X-ray fluorescence analysis of lead in teeth of urban children in situ: correlation between the tooth lead level and the concentration of blood lead and free erythroporphyrins. Environ Res (1978) 0.99
Prevalence of morning hyperglycaemia: determinants of fasting blood glucose concentrations in insulin-treated diabetics. Diabet Med (1985) 0.99
Antihyperglycemic and antidyslipidemic agent from Aegle marmelos. Bioorg Med Chem Lett (2006) 0.99
Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross-over trial in people with Type 1 diabetes. Diabet Med (2006) 0.99
Measurement of free insulin concentrations: the influence of the timing of extraction of insulin antibodies. Diabetologia (1985) 0.99
A crossover comparison of continuous subcutaneous insulin infusion (CSII) against multiple insulin injections in insulin-dependent diabetic subjects: improved control with CSII. Diabetes Care (1984) 0.99
Human insulin. Clin Endocrinol Metab (1982) 0.98
Primary-care observational database study of the efficacy of GLP-1 receptor agonists and insulin in the UK. Diabet Med (2013) 0.98
CHEK2 variants in susceptibility to breast cancer and evidence of retention of the wild type allele in tumours. Br J Cancer (2002) 0.97
A laboratory trial of two new blood-glucose reflectance meters featuring automatic external calibration. Ann Clin Biochem (1984) 0.97
Identifying the impact of diabetes research. Diabet Med (2006) 0.97
Morphology of palpably abnormal injection sites and effects on absorption of isophane(NPH) insulin. Diabet Med (1990) 0.96
Friedewald equation underestimates low-density lipoprotein cholesterol at low concentrations in young people with and without Type 1 diabetes. Diabet Med (2010) 0.96
Relationship between insulin sensitivity, insulin secretion and glucose tolerance in cirrhosis. Hepatology (1991) 0.96
Plasma free insulin profiles after administration of insulin by jet and conventional syringe injection. Diabetes Care (1982) 0.95
Bacterial superantigens induce down-modulation of CC chemokine responsiveness in human monocytes via an alternative chemokine ligand-independent mechanism. J Immunol (1999) 0.94
Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor gene correlates with poor differentiation in early breast carcinomas. Br J Cancer (1997) 0.94
A propensity score matched comparison of different insulin regimens 1 year after beginning insulin in people with type 2 diabetes. Diabetes Obes Metab (2013) 0.94
Oral immunization with L-forms of Vibrio cholerae in human volunteers. Infect Immun (1972) 0.94
Antenatal diagnosis of glutaricaciduria type II. Lancet (1983) 0.94
Antibacterial activity of human prostatic fluid. Invest Urol (1967) 0.93
N of 1 trials. Practical tools for medication management. Aust Fam Physician (2000) 0.93